No registrations found.
Source
Brief title
Health condition
Subacromial Pain Syndrome; Subacromial Impingement Syndrome; chronic shoulder pain.
Sponsors and support
Intervention
Outcome measures
Primary outcome
Clinical outcomes are pain (Visual Analogue Scale), arm-shoulder function (Constant score), bio-physical-social health (RAND-36, Shoulder Rating Questionnaire) and, self-reported quality of life (Western Ontario Rotator Cuff index). Co-contraction as assessed with EMG will be expressed using the Activation Ratio ([AR]; range [-1 to1]), indicating the task-related amount of antagonist activation relative to the same muscle’s degree of agonistic activation, corresponding to 1 in case of pure agonist muscle activation and -1 in case of pure antagonistic activation.
Secondary outcome
Movement complexity and proprioception, factors that potentially associate with the clinical course of SAPS will be assessed using electromagnetic motion analysis (Flock of Birds, FoB). Additionally, we will evaluate the content of care provided and compliance of the patients by asking the patients to fill out a registration form on the frequency, duration and content of treatment.
Background summary
In patients with Subacromial Pain Syndrome (SAPS), there is a potentially treatable muscle activation imbalance between arm abductors and arm adductors, that leads to the typical overloading of subacromial tissues during abduction. This muscular imbalance may result from declines in proprioception and/or movement complexity and can be restored with enhanced co-contraction. It has been recently shown that, compared to age-matched controls, patients with SAPS have decreased co-contraction levels of arm adductors (humeral depressors) during abduction. Furthermore, it has been shown that an increase in adductor co-contraction associates with a favourable clinical course in patients with SAPS. Based on these findings and clinical observations, we propose that active enhancement of adductor co-contraction in patients with SAPS might be a beneficial treatment option.
This study aims to assess if actively training adductor co-contraction in patients with SAPS is clinically effective. A specific therapy protocol is already in practice in the Leiden University Medical Center (LUMC) dept. of Physical Therapy. Secondly, we want to investigate if this clinical improvement is associated with increased co-contraction levels by electromyographic (EMG) assessment. Additionally, kinematic analysis will be performed in order to evaluate factors also associated with clinical outcome, including movement complexity and proprioception.
Study objective
The a-priori hypothesis is, that clinical improvement of patients with SAPS is related to increased co-contraction as trained during scooping therapy.
Study design
Clinical effect (questionnaires) and co-contraction of the Latissimus Dorsi, Teres Major, Pectoralis Major and/or Deltoid Muscle (electromyography, EMG) will be quantified in three study-related visits (baseline, 3 months, 1 year). The intervention period lasts 3 months and the effects will be monitored after 1 year.
Intervention
Randomised controlled trial with two study groups comparing the control group (standard care) with the intervention group (standard care combined with a specific physical therapy protocol aimed at enhancing adductor co-contraction).
Inclusion criteria
- Chronic shoulder pain (>3months).
- Suspicion of subacromial origin of pain (e.g. combination of positive painful arc test, Hawkins-Kennedy test and empty can test).
- Presence of conventional radiographs.
Exclusion criteria
- Younger than 18 years of age;
- History of fracture or dislocation of the shoulder;
- History of surgery around the shoulder;
- Clinical and/or radiographic signs of comorbidities or alternative diagnoses of the affected shoulder (glenohumeral instability, glenohumeral/acromioclavicular osteoarthritis or arthritis, rheumatic disorder, history of trauma of the affected shoulder, capsulitis adhesiva, complete (full thickness) rotator cuff rupture, cervical radiculopathy,plexus lesions). - Tendinitis calcarea, although part of saps; requires different treatment methods.
- Neoplasms;
- Pregnancy;
- Cognitive impairment;
- Electronic implants (e.g. Implantable Cardioverter Defibrillator, pacemaker);
- Insufficient Dutch language skills;
- Refusing physical therapy treatment (for example, due to the absence of reimbursement);
- Received physical therapy treatment in past three months;
- Refusing subacromial corticosteroid injection;
- Received subacromial corticosteroid injection in last month;
- No informed consent.
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL8797 |
Other | METC LDD : P19.080 |